Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 22.10
-0.40 (-1.78%)
Last updated: Mar 6, 2026, 11:30 AM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 129.77 million as of March 6, 2026. Its market cap has increased by 8.66% in one year.
Market Cap
129.77M
Enterprise Value
277.28M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.95
Stock Price
22.10
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 129.77M, a decrease of -46.03%. That is a compound annual growth rate of -14.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 128.62M | -9.72% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 147.73M |
| BioVersys AG | 149.71M |
| Santhera Pharmaceuticals Holding AG | 226.17M |
| Newron Pharmaceuticals | 379.89M |
| Basilea Pharmaceutica AG | 645.31M |
| Idorsia | 920.51M |
| EvoNext Holdings | 6.66M |
| Addex Therapeutics | 5.36M |